Novo Nordisk's pricing strategies inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of rate gouging, stating the stark contrast involving U.S. rates and those in Europe and copyright. Novo Nordisk is linked to authorities funded c